Senate Pandemic Bill Advances Without Provision Expediting FDA Reviews Based On Foreign Data

Senate committee approves legislation aimed at strengthening the US public health and medical preparedness and response system. Bill includes several provisions impacting FDA but not its 'gold standard' approval process.

Bill Has Bipartisan Support In US Senate • Source: Alamy

The Senate Health, Education, Labor and Pensions Committee approved legislation geared toward improving the nation’s public health response to future pandemics on 15 March but voted against including a proposed amendment that would have set up an expedited drug and vaccine review process at FDA based on foreign data.

More from US FDA

More from Agency Leadership